News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

COREX Opens a State-of-the-Art Pharmaceutical Depot in Moscow, Russia


9/5/2012 7:32:00 AM

MOSCOW--(Marketwire - September 05, 2012) -

COREX LLC has announced that it has opened a state-of-the-art, audit-ready, GxP compliant pharmaceutical depot for study drugs and clinical trial materials located in Moscow, Russia. COREX specializes in clinical research support and offers a full range of depot services, including storage in all temperature conditions, as well as assistance in customs clearance and obtaining required permits and licenses, importation/exportation, regulatory support, extension labeling / relabeling, temperature controlled distribution and local procurement of comparators.

"When we started this project, our overarching ambition was to build a facility that would compete with top level global depots and that would bring clinical trial logistics services in Russia to a new quality and business culture levels," said Dr. Vladimir Bogin, CEO of COREX. "What uniquely positions COREX, is its ability to assemble a team of thoroughly trained and experienced professionals who have intricate knowledge of local and global regulations," continued Dr. Bogin. "Among its strengths is depot's strategic location between Moscow's Vnukovo and Domodedovo airports (major domestic hubs), which enables us to guarantee prompt delivery to local Russian sites," added Dr. Andrey Tarakanov, Managing Director of COREX.

COREX has been recently awarded an unrestricted pharmaceutical license that allows it to conduct a full spectrum of depot and distribution services in Russia.

If you are interested in learning more about COREX, please visit us at www.corex-depot.com or email us at inquiry@corex-depot.com


Denis Volkov
Director of Business Development
COREX
1, Komsomolskaya Street
Podolsk, Moscow region
Russia 142100
Phone: +7 (495) 532 62 46
Email: Email Contact

Digg this    Bookmark with del.icio.us    Add to Newsvine

Technorati:


Read at BioSpace.com

comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES